Carregant...

Lack of an Effect of Ritonavir Alone and Lopinavir-Ritonavir on the Pharmacokinetics of Fenofibric Acid in Healthy Volunteers

STUDY OBJECTIVE: As we previously observed a significant 41% reduction in gemfibrozil exposure after 2 weeks of lopinavir-ritonavir administration, we sought to determine the influence of lopinavir-ritonavir and ritonavir alone on the pharmacokinetics of fenofibric acid, an alternative to gemfibrozi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmacotherapy
Autors principals: Gordon, Lori A., Malati, Christine Y., Hadigan, Colleen, McLaughlin, Mary, Alfaro, Raul M., Calderón, Mónica M., Kovacs, Joseph A., Penzak, Scott R.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5548178/
https://ncbi.nlm.nih.gov/pubmed/26799348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1682
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!